<p>Mags.DO5 purified DM/DO was immobilized on anti-His antibody coupled chip surface to a level of 2000–3000 RU. Receptive DR1 molecules were generated from DR1/HA(Y308A) peptide complexes by removing the excess peptide by G-50 size-exclusion spin columns, adding DM and allowing the peptide to dissociate for 20 minutes at 37°C. Immediately after the 20 minute incubation 4 µM receptive DR1 with 2 µM DM was injected over the captured DM/DO at a rate of 1 µL/min and a constant flow-cell temperature of 37°C for 50 minutes (green trace). As a control, prior to the injection of receptive DR1 molecules, 2 µM DM (blue trace), or 4 µM DR1/HA(306–318) (red trace) were injected at the same flow rate and temperature. Data shown are representative of tw...
<p>(a) Competitive binding analysis of P1, P3 and P7 MTSL-Cys substituted HA peptide variants to DR1...
Antigen presentation is the first step in generating an adaptive immune response to a foreign pathog...
Major histocompatibility complex (MHC) class I molecules bind peptides in the endoplasmic reticulum ...
<p>(A) SPR sensograms of constitutively receptive DR1βG86Y (4µM) binding to DO. Ni-NTA purified DO w...
<p>(A) Association (left) and dissociation (right) of HA(306–318) peptide to DR1 molecules with no a...
<p>(A) Association of HA(Y308A) peptide to DR1 molecules in the presence of coinfected DM/DO complex...
<p>(A–C) SPR binding curves for DR1 molecules covalently linked to the P6 position of peptides indic...
<p>(A) Association (left) and dissociation (right) of CII(259–273) peptide to DR1 molecules with no ...
<p>(A, B) DR1β mutants H81A, V85S and V85D and DRα mutant S53A were compared with wild type DR1 comp...
<p>(A) DO (Ni-NTA purified) was immobilized on an anti-His antibody surface (blue trace). After a br...
<p>The ability of Y1MxN photocleavable peptide to bind DR1 was measured in a competition binding ass...
Processing of antigens for presentation to helper T cells by MHC class II involves HLA-DM (DM) and H...
The mechanisms of HLA-DM catalyzed peptide exchange remain uncertain. We found that all stages of th...
<p>(a) Dissociation rate of peptides from HLA-DR1 in the presence of DM was measured as described in...
AbstractHLA-DM (DM) edits major histocompatibility complex class II (MHCII)-bound peptides in endocy...
<p>(a) Competitive binding analysis of P1, P3 and P7 MTSL-Cys substituted HA peptide variants to DR1...
Antigen presentation is the first step in generating an adaptive immune response to a foreign pathog...
Major histocompatibility complex (MHC) class I molecules bind peptides in the endoplasmic reticulum ...
<p>(A) SPR sensograms of constitutively receptive DR1βG86Y (4µM) binding to DO. Ni-NTA purified DO w...
<p>(A) Association (left) and dissociation (right) of HA(306–318) peptide to DR1 molecules with no a...
<p>(A) Association of HA(Y308A) peptide to DR1 molecules in the presence of coinfected DM/DO complex...
<p>(A–C) SPR binding curves for DR1 molecules covalently linked to the P6 position of peptides indic...
<p>(A) Association (left) and dissociation (right) of CII(259–273) peptide to DR1 molecules with no ...
<p>(A, B) DR1β mutants H81A, V85S and V85D and DRα mutant S53A were compared with wild type DR1 comp...
<p>(A) DO (Ni-NTA purified) was immobilized on an anti-His antibody surface (blue trace). After a br...
<p>The ability of Y1MxN photocleavable peptide to bind DR1 was measured in a competition binding ass...
Processing of antigens for presentation to helper T cells by MHC class II involves HLA-DM (DM) and H...
The mechanisms of HLA-DM catalyzed peptide exchange remain uncertain. We found that all stages of th...
<p>(a) Dissociation rate of peptides from HLA-DR1 in the presence of DM was measured as described in...
AbstractHLA-DM (DM) edits major histocompatibility complex class II (MHCII)-bound peptides in endocy...
<p>(a) Competitive binding analysis of P1, P3 and P7 MTSL-Cys substituted HA peptide variants to DR1...
Antigen presentation is the first step in generating an adaptive immune response to a foreign pathog...
Major histocompatibility complex (MHC) class I molecules bind peptides in the endoplasmic reticulum ...